Skip to main content

Animations

MJFF Publications

7461 - 7470 of 9140 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79771
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth Applications
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000525698
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00395-8
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Highly efficient generation of isogenic pluripotent stem cell models using prime editing
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79208
    Citation Count: 65
  • Summary Details
    OPEN
    Title: Revisiting the specificity and ability of phospho-S129 antibodies to capture alpha-synuclein biochemical and pathological diversity
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00388-7
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-20261-0
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Using former carers’ expertise in peer support for carers of people with Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00381-0
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review
    Journal Name: Dystonia
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/dyst.2022.10359
    Citation Count: 37
  • Summary Details
    OPEN
    Title: PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain
    Journal Name: Biochemical Journal
    Publisher: Portland Press Ltd.
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1042/bcj20220308
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-022-01932-x
    Citation Count: 283
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.